Aethlon Medical
AEMD
7 hedge funds and large institutions have $1.26M invested in Aethlon Medical in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
1.42% less ownership
Funds ownership: 7.43% → 6.01% (-1.4%)
25% less capital invested
Capital invested by funds: $1.69M → $1.26M (-$427K)
30% less funds holding
Funds holding: 10 → 7 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$256K |
| 2 |
VF
Virtu Financial
New York
|
-$70K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$66K |
AEMD Hedge Fund Activity: Q3 2018 in Review
7 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2018, worth a combined $1.26M — down 25% from $1.69M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AEMD and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Millennium Management, exiting entirely with an estimated $256K sold.
- 7 institutional investors held Aethlon Medical (AEMD) as of Q3 2018, down from 10 in Q2 2018.
- Funds reported $1.26M of Aethlon Medical stock for Q3 2018, down 25% quarter-over-quarter.
- 0 funds opened new Aethlon Medical positions in Q3 2018 and 3 closed out, a net change of -3 holders.
- The largest Aethlon Medical seller in Q3 2018 was Millennium Management, an estimated $256K sold.
Based on aggregated 13F filings for Q3 2018.